DEA Archived Press Releases

Press Releases before January 20, 2025
858 Results - Showing 221 to 230
PRESS RELEASE

Former Miami-Dade County resident sentenced to over 12 years in prison for attempted international narcotics trafficking

MIAMI - On Sept. 28, 2018, Richard Senese, 39, a former Miami-Dade County resident was sentenced to 12.5 years in prison, to be followed by 5 years of supervised release, for attempted international narcotics trafficking. Senese, formerly of Hialeah, previously pled guilty to attempting to import cocaine into the United...
PRESS RELEASE

Retired nurse sentenced to five years in prison for drug trafficking and money laundering

NEW HAVEN, Conn. – Brian D. Boyle, Special Agent in Charge of the DEA’s New England Division, and John H. Durham, United States Attorney for the District of Connecticut, announced that Christine Miles, 59, of Windsor Locks, was sentenced today by U.S. District Judge Jeffrey A. Meyer in New Haven...
PRESS RELEASE

25-plus Chicago defendants face drug charges for alleged fentanyl or fentanyl-laced heroin sales

CHICAGO - More than 25 individuals are facing federal or state drug charges for allegedly selling pure fentanyl or fentanyl-laced heroin in Chicago. Many of the defendants sold narcotics to an undercover law enforcement officer earlier this year, according to the charges. Several of the sales occurred in daytime hours...
PRESS RELEASE

Convenience store manager sentenced to prison for trafficking synthetic cannabinoids

ROCHESTER, N.Y. – Acting Special Agent in Charge Keith Kruskall, New York Division, U.S. Drug Enforcement Administration, and U.S. Attorney James P. Kennedy, Jr. announced today that Mohammed Akram, 30, of Rochester, N.Y., who was convicted of misbranding food, was sentenced by U.S. District Judge Elizabeth A. Wolford to 60...
PRESS RELEASE

Colombian veterinarian pleads guilty in Brooklyn federal court to heroin importation conspiracy

BROOKLYN, N.Y. – Andres Lopez Elorez pleaded guilty today before U. S. Magistrate Judge Robert M. Levy in federal court in Brooklyn to conspiring to import heroin into the United States. Richard P. Donoghue, U. S. Attorney for the Eastern District of New York, and James J. Hunt, Special Agent...
PRESS RELEASE

Buffalo man charged with selling fentanyl that caused serious bodily injury

BUFFALO, N.Y. - U.S. Attorney James P. Kennedy, Jr. and Special Agent in Charge James Hunt, U.S. Drug Enforcement Administration, New York Division announced today that a federal grand jury has returned an indictment charging Julian Beavers, a/k/a Ock, a/k/a Marcel Ceasar, a/k/a BJ, 32, of Buffalo, New York, with...
PRESS RELEASE

Former Honduran National Police Chief sentenced to 14 years in prison for conspiring to import cocaine into the United States and to possess firearms

NEW YORK - Raymond Donovan, Special Agent in Charge of the Drug Enforcement Administration’s Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today that Carlos Alberto Valladares Garcia, a former high-ranking member of the Honduran National Police, was sentenced...
PRESS RELEASE

Washington man sentenced to over 12 years in prison for meth offense

MISSOULA, Mont., - Salomon Mejia Preciado, a 36-year-old resident of Yakima, Washington, was sentenced today to 151 months in prison to be followed by 5 years of supervised release. Preciado pleaded guilty to conspiracy to distribute methamphetamine. Preciado is a former federal felon and was prosecuted in the Eastern District...
PRESS RELEASE

Former Miami-Dade County resident sentenced to more than 8 years in prison for bank fraud and money laundering schemes

MIAMI - A former Miami-Dade County resident was sentenced to 97 months in prison, to be followed by five years of supervised release, and was ordered to pay $722,000 in restitution for his roles in bank fraud and money laundering schemes. Jose Orlando Sanchez Cristancho, a.k.a. Orlando Sanchez , 57...
PRESS RELEASE

FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...